Browse the corpus

REFERENCES “A Comparison of Reteplase With Alteplase for Acute Myocardial Infarction. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO III) Investigators,” N Engl J Med , 1997, 337(16):1118-23. [PubMed 9340503 ] Adams HP Jr, del Zoppo G, Alberts MJ, et al, "Guidelines for the Early Management of Adults With Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology Affirms the Value of This Guideline as an Educational Tool for Neurologists," Stroke , 2007, 38(5):1655-711. [PubMed 17431204 ] Alberts MJ, Bernstein RA, Naccarelli GV, et al, “Using Dabigatran in Patients With Stroke: A Practical Guide for Clinicians,” Stroke , 2012, 43(1):271-9. [PubMed 22156688 ] Antman EM, Anbe SC, Alpert JS, et al, “ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction - Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction),” Circulation , 2004, 110(5):588-636. [PubMed 15289388 ] Antman EM, Hand M, Armstrong PW, et al, “2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines,” J Am Coll Cardiol , 2008, 51(2):210-49. [PubMed 18191746 ] Bonow RO, Carabello BA, Chatterjee K, et al, “2008 Focused Update Incorporated into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons,” Circulation , 2008, 118(15):e523-661. [PubMed 18820172 ]

Bonow RO, Carabello BA, Chatterjee K, et al, “2008 Focused Update Incorporated into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons,” Circulation , 2008, 118(15):e523-661. [PubMed 18820172 ] Böttiger BW, Bode C, Kern S, et al,“Efficacy and Safety of Thrombolytic Therapy After Initially Unsuccessful Cardiopulmonary Resuscitation: A Prospective Clinical Trial,” Lancet , 2001, 357(9268):1583-5. [PubMed 11377646 ] Bradley JS, Byington CL, Shah SS, et al. “The Management of Community-Acquired Pneumonia in Infants and Children Older Than 3 Months of Age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America”, Clin Infect Dis , 2011, 53(7):e25-76. [PubMed 21880587 ] Broderick J, Connolly S, Feldmann E, et al, “Guidelines for the Management of Spontaneous Intracerebral Hemorrhage in Adults: 2007 Update: A Guideline From the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group,” Stroke , 2007, 38(6):2001-23. Available at file://stroke.ahajournals.org/cgi/content/short/STROKEAHA.107.183689 [PubMed 17478736 ] Chan J, Rees CR, Song AK, et al, “Usefulness of Catheter-Directed Thrombolysis Using Alteplase in Peripheral Vascular Occlusion,” Proc (Bayl Univ Med Cent), 2001, 14(1):3-7. [PubMed 16369579 ] Cohen V, Jellinek SP, Teperikidis L, et al, “Room-Temperature Storage of Medications Labeled for Refrigeration,” Am J Health-Syst Pharm , 2007, 64(16):1711-15. [PubMed 17687059 ] Colice GL, Curtis A, Deslauriers J, et al, “Medical and Surgical Treatment of Parapneumonic Effusions: An Evidence-Based Guideline,” Chest , 2000, 118(4):1158-71. [PubMed 11035692 ] Comerota AJ and Schmieder FA, “Intraoperative Lytic Therapy: Agents and Methods of Administration,” Semin Vasc Surg , 2001, 14(2):132-42. [PubMed 11400089 ]

Colice GL, Curtis A, Deslauriers J, et al, “Medical and Surgical Treatment of Parapneumonic Effusions: An Evidence-Based Guideline,” Chest , 2000, 118(4):1158-71. [PubMed 11035692 ] Comerota AJ and Schmieder FA, “Intraoperative Lytic Therapy: Agents and Methods of Administration,” Semin Vasc Surg , 2001, 14(2):132-42. [PubMed 11400089 ] del Zoppo GJ, Saver JL, Jauch EC, et al, “Expansion of the Time Window for Treatment of Acute Ischemic Stroke With Intravenous Tissue Plasminogen Activator: A Science Advisory From the American Heart Association/American Stroke Association,” Stroke , 2009, 40(8):2945-8. [PubMed 19478221 ] Disini L, Wilson P, and Cockburn JF, “Successful Intra-Arterial Alteplase Infusion is a Predictor of 12-Month Limb Survival in Patients With Lower Limb Arterial Occlusion,” Clin Radiol , 2008, 63(6):636-41. [PubMed 18455554 ] Field JM, Hazinski MF, Sayre MR, et al, “Part 1: Executive Summary: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care,” Circulation , 2010, 122 (18 Suppl 3):640-56. [PubMed 20956217 ] Guyatt GH, Akl EA, Crowther M, et al, “Executive Summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines,” Chest , 2012, 141(2 Suppl):7-47. [PubMed 22315257 ] Hacke W, Kaste M, Bluhmki E, et al, "Thrombolysis With Alteplase 3 to 4.5 Hours After Acute Ischemic Stroke," N Engl J Med , 2008, 359(13):1317-29. [PubMed 18815396 ] Hamblin SE and Furmanek DL, “Intrapleural Tissue Plasminogen Activator for the Treatment of Parapneumonic Effusion,” Pharmacotherapy , 2010, 30(8):855-62. [PubMed 20653362 ] Hawkins JA, Scaife ES, Hillman ND, et al, “Current Treatment of Pediatric Empyema,” Semin Thorac Cardiovasc Surg , 2004, 16(3):196-200. [PubMed 15619185 ]

Hamblin SE and Furmanek DL, “Intrapleural Tissue Plasminogen Activator for the Treatment of Parapneumonic Effusion,” Pharmacotherapy , 2010, 30(8):855-62. [PubMed 20653362 ] Hawkins JA, Scaife ES, Hillman ND, et al, “Current Treatment of Pediatric Empyema,” Semin Thorac Cardiovasc Surg , 2004, 16(3):196-200. [PubMed 15619185 ] Hirsch AT, Haskal ZJ, Hertzer NR, et al, “ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic). A Collaborative Report of the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease),” Circulation , 2006, 113(11):e463-654. [PubMed 16549646 ] Jaff MR, McMurtry MS, Archer SL, et al, “Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension: A Scientific Statement from the American Heart Association,” Circulation , 2011, 123(16):1788-830. [PubMed 21422387 ] Konstantinides S, Geibel A, Heusel G, et al, "Heparin Plus Alteplase Compared With Heparin Alone in Patients With Submassive Pulmonary Embolism," N Engl J Med , 2002, 347(15):1143-50. [PubMed 12374874 ] Kushner FG, Hand M, Smith SC, et al, “2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines,” J Am Coll Cardiol , 2009, 54(23):2205-41. [PubMed 19942100 ] Leonard MC and Shermock KM, “Using Efficacy, Safety, and Cost Data to Support a Formulary Decision Regarding Thrombolytic Therapy,” Semin Vasc Surg , 2001, 14(2):150-5. [PubMed 11400091 ]

Kushner FG, Hand M, Smith SC, et al, “2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines,” J Am Coll Cardiol , 2009, 54(23):2205-41. [PubMed 19942100 ] Leonard MC and Shermock KM, “Using Efficacy, Safety, and Cost Data to Support a Formulary Decision Regarding Thrombolytic Therapy,” Semin Vasc Surg , 2001, 14(2):150-5. [PubMed 11400091 ] Lundergan CF, Reiner JS, McCarthy WF, et al, “Clinical Predictors of Early Infarct-Related Artery Patency Following Thrombolytic Therapy: Importance of Body Weight, Smoking History, Infarct-Related Artery and Choice of Thrombolytic Regimen: The GUSTO-I Experience. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries,” J Am Coll Cardiol , 1998, 32(3):641-7. [PubMed 9741505 ] O'Connor RE, Brady W, Brooks SC, et al, “Part 10: Acute Coronary Syndromes: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care,” Circulation , 2010, 122(18 Suppl 3):787-817. [PubMed 20956226 ] O'Gara PT, Kushner FG, Ascheim DD, et al, "2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines," Circulation , 2012, 127(4):e362-425. [PubMed 3247304 ] Ouriel K, “Current Status of Thrombolysis for Peripheral Arterial Occlusive Disease,” Ann Vasc Surg , 2002, 16(6):797-804. [PubMed 12391507 ] Ouriel K and Kandarpa K, “Safety of Thrombolytic Therapy With Urokinase or Recombinant Tissue Plamsminogen Activator for Peripheral Arterial Occlusion: A Comprehensive Compilation of Published Work,” J Endovasc Ther , 2004, 11(4):436-46. [PubMed 15298504 ] Ponec D, Irwin D, Haire WD, et al, “Recombinant Tissue Plasminogen Activator (Alteplase) for Restoration of Flow in Occluded Central Venous Access Devices: A Double-Blind Placebo-Controlled Trial - The Cardiovascular Thrombolytic to Open Occluded Lines (COOL) Efficacy Trial,” J Vasc Interv Radiol , 2001, 12(8):951-5. [PubMed 11487675 ]

Ponec D, Irwin D, Haire WD, et al, “Recombinant Tissue Plasminogen Activator (Alteplase) for Restoration of Flow in Occluded Central Venous Access Devices: A Double-Blind Placebo-Controlled Trial - The Cardiovascular Thrombolytic to Open Occluded Lines (COOL) Efficacy Trial,” J Vasc Interv Radiol , 2001, 12(8):951-5. [PubMed 11487675 ] Rahman NM, Maskell NA, West A, et al, “Intrapleural Use of Tissue Plasminogen Activator and DNase in Pleural Infection,” N Engl J Med , 2011, 365(6):518-26. [PubMed 21830966 ] “Results of a Prospective, Randomised Trial Evaluating Surgery Versus Thrombolysis for Ischemia of the Lower Extremity. The STILE Trial,” Ann Surg , 1994, 220(3):251-66; discussion 266-8. [PubMed 8092895 ] Semba CP, Bakal CW, Calis KA, et al, “Alteplase as an Alternative to Urokinase. Advisory Panel on Catheter-Directed Thrombolytic Therapy,” J Vasc Interv Radiol , 2000, 11(3):279-87. [PubMed 10735420 ] St Peter SD, Tsao, K, Harrison C, et al, “Thorascopic Decortication vs Tube Thoracostomy With Fibrinolysis for Empyema in Children: A Prospective, Randomized Trial,” J Pediatr Surg , 2009, 44(1):106-11. [PubMed 19159726 ] Sugimoto K, Hofmann LV, Razavi MK, et al, “The Safety, Efficacy, and Pharmacoeconomics of Low-Dose Alteplase Compared With Urokinase for Catheter-Directed Thrombolysis of Arterial and Venous Occlusions,” J Vasc Surg , 2003, 37(3):512-7. [PubMed 12618684 ] The Gusto Angiographic Investigators, “The Effects of Tissue Plasminogen Activator, Streptokinase, or Both on Coronary-Artery Patency, Ventricular Function, and Survival After Acute Myocardial Infarction,” N Engl J Med , 1993, 329(22):1615-22. [PubMed 8232430 ] “Thrombolysis in the Management of Lower Limb Peripheral Arterial Occlusion - A Consensus Document. Working Party on Thrombolysis in the Management of Limb Ischemia,” J Vasc Interv Radiol , 2003, 14(9 Pt 2):337-49. [PubMed 14514841 ] “Tissue Plasminogen Activator for Acute Ischemic Stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group,” N Engl J Med , 1995, 333(24):1581-7. [PubMed 7477192 ] Topol EJ, “Reperfusion Therapy for Acute Myocardial Infarction With Fibrinolytic Therapy or Combination Reduced Fibrinolytic Therapy and Platelet Glycoprotein IIb/IIIa Inhibition: The GUSTO V Randomized Trial. GUSTO V Investigators,” Lancet , 2001, 357(9272):1905-14. [PubMed 11425410 ]

“Tissue Plasminogen Activator for Acute Ischemic Stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group,” N Engl J Med , 1995, 333(24):1581-7. [PubMed 7477192 ] Topol EJ, “Reperfusion Therapy for Acute Myocardial Infarction With Fibrinolytic Therapy or Combination Reduced Fibrinolytic Therapy and Platelet Glycoprotein IIb/IIIa Inhibition: The GUSTO V Randomized Trial. GUSTO V Investigators,” Lancet , 2001, 357(9272):1905-14. [PubMed 11425410 ] Zacharias JM, Weatherston CP, Spewak CR, et al, “Alteplase Versus Urokinase for Occluded Hemodialysis Catheters,” Ann Pharmacother , 2003, 37(1):27-33. [PubMed 12503929 ] Topic 8478 Version 44.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.6- C21.56 Licensed to: AsanBook Dig. Med. Lib. | Support Tag: [1004-118.195.65.244-3BAB8F1ACB-S244013.14]